Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C‐dependent mechanism

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Neuropharmacology

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2016.10.010PMID 27743930PMCID PMC5148695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Compromising the phosphodependent regulation of the GABAAR β3 subunit reproduces the core phenotypes of autism spectrum disorders

  2015influential reference
• Neuroactive Steroids. 1. Positive Allosteric Modulators of the (γ-Aminobutyric Acid)A Receptor: Structure-Activity Relationships of Heterocyclic Substitution at C-21.

  2015influential reference
• Modulation of neurosteroid potentiation by protein kinases at synaptic- and extrasynaptic-type GABAA receptors

  2015cited by this paper
• Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors

  2014influential reference
• New perspectives in neurosteroid action: open questions for future research

  2014cited by this paper
• Enhanced Tonic Inhibition Influences the Hypnotic and Amnestic Actions of the Intravenous Anesthetics Etomidate and Propofol

  2013cited by this paper
• Protein kinase C regulates tonic GABAA receptor-mediated inhibition in the hippocampus and thalamus

  2013cited by this paper
• Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.

  2012cited by this paper
• Protein Kinase C Phosphorylation Regulates Membrane Insertion of GABAA Receptor Subtypes That Mediate Tonic Inhibition*

  2010influential reference
• Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function

  2009cited by this paper
• Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome.

  2009cited by this paper
• Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia.

  2009cited by this paper
• Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease.

  2008cited by this paper
• The expression of GABAAβ subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells

  2008cited by this paper
• GABA(A)R plasticity during pregnancy: relevance to postpartum depression.

  2008cited by this paper
• Deficits in Phosphorylation of GABAA Receptors by Intimately Associated Protein Kinase C Activity Underlie Compromised Synaptic Inhibition during Status Epilepticus

  2008cited by this paper
• Activation of GABAA receptors: views from outside the synaptic cleft.

  2007cited by this paper
• The GABAA receptor: a novel target for treatment of fragile X?

  2007cited by this paper
• A new naturally occurring GABAA receptor subunit partnership with high sensitivity to ethanol

  2007cited by this paper
• Neuroactive steroids

  2007cited by this paper
• Extrasynaptic αβ subunit GABAA receptors on rat hippocampal pyramidal neurons

  2006cited by this paper
• GABAA receptor α4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol

  2006cited by this paper
• Expression profiling suggests underexpression of the GABA(A) receptor subunit delta in the fragile X knockout mouse model.

  2006cited by this paper
• Phospho-dependent binding of the clathrin AP2 adaptor complex to GABAA receptors regulates the efficacy of inhibitory synaptic transmission.

  2005cited by this paper
• Brain-Derived Neurotrophic Factor Modulates Fast Synaptic Inhibition by Regulating GABAA Receptor Phosphorylation, Activity, and Cell-Surface Stability

  2004cited by this paper
• Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha5 subunit-containing gamma-aminobutyric acid type A receptors.

  2004cited by this paper
• Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptors

  2004cited by this paper
• Tonically active GABA A receptors: modulating gain and maintaining the tone.

  2004cited by this paper
• Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells.

  2002cited by this paper
• A Significant Part of Native γ-Aminobutyric AcidAReceptors Containing α4 Subunits Do Not Contain γ or δ Subunits*

  1999cited by this paper
• Neuroactive steroids

  1992cited by this paper

• Pregnancy's lasting imprint: Late pregnancy allopregnanolone alters rat fear recall and medial prefrontal cortex activity.

  2026cites this paper
• Recent advances in GABAA receptor targeting ligands.

  2026cites this paper
• Unravelling the multifaceted actions of neurosteroids: Machine learning and in vitro screening for novel target discovery

  2025cites this paper
• Effects of progestogen neurosteroids on locomotor activity in zebrafish embryos and larvae

  2025cites this paper
• Membrane progesterone and oestrogen receptors modulate GABAergic transmission in the prefrontal cortex of prepubertal male, but not female, mice

  2025cites this paper
• Synthesis and Evaluation of a Novel Zuranolone Analog with High GABAA Receptor PAM Activity and Excellent Pharmacokinetic Profiles

  2025cites this paper
• New Directions in Neurosteroid Therapeutics in Neuropsychiatry.

  2025cites this paper
• Neuroactive steroids activate membrane progesterone receptors to induce sex specific effects on protein kinase activity

  2025cites this paper
• Effect of two novel GABAA receptor positive allosteric modulators on neuropathic and inflammatory pain in mice.

  2025cites this paper
• Neurosteroids: a lifelong impact on brain health

  2025cites this paper
• Emerging Evidence for Endogenous Neurosteroid Modulation of Pro-Inflammatory and Anti-Inflammatory Pathways that Impact Neuropsychiatric Disease.

  2024cites this paper
• Emerging evidence for pregnane steroid therapeutics for alcohol use disorders.

  2024cites this paper
• LPM682000012, a Synthetic Neuroactive Steroid That Ameliorates Epileptic Seizures by Downregulating the Serpina3n/NF-κB Signaling Pathway

  2024cites this paper
• Neurosteroid [3α,5α]-3-Hydroxy-pregnan-20-one Enhances the CX3CL1-CX3CR1 Pathway in the Brain of Alcohol-Preferring Rats with Sex-Specificity

  2024cites this paper
• Sustained Inhibition of GABA-AT by OV329 Enhances Neuronal Inhibition and Prevents Development of Benzodiazepine Refractory Seizures

  2024influential citation
• Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders

  2024cites this paper
• Neurosteroid Modulation of Synaptic and Extrasynaptic GABAA Receptors of the Mouse Nucleus Accumbens

  2024cites this paper
• A Randomized Phase 2 KINETIC Trial Evaluating SAGE‐324/BIIB124 in Individuals with Essential Tremor

  2024cites this paper
• The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrated analysis of 4 randomized clinical trials.

  2024cites this paper
• Distinct mechanisms of allopregnanolone and diazepam underlie neuronal oscillations and differential antidepressant effect

  2024cites this paper
• Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial.

  2023cites this paper
• Efficacy and safety of zuranolone for the treatment of depression: A systematic review and meta-analysis.

  2023cites this paper
• Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic

  2023cites this paper
• Corticosteroids as Selective and Effective Modulators of Glycine Receptors

  2023cites this paper
• GABAA receptors as targets for treating affective and cognitive symptoms of depression.

  2023cites this paper
• Neurosteroid Influence on Affective Tone.

  2023cites this paper
• Neurosteroids: mechanistic considerations and clinical prospects

  2023cites this paper
• Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder

  2023cites this paper
• Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

  2023cites this paper
• Preventing Phosphorylation of the GABAAR β3 Subunit Compromises the Behavioral Effects of Neuroactive Steroids

  2022cites this paper
• Therapeutic potential of GABAA receptor subunit expression abnormalities in fragile X syndrome

  2022cites this paper
• The immediate and maintained effects of neurosteroids on GABAA receptors

  2022cites this paper
• Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.

  2022cites this paper
• Emerging drugs for the treatment of major depressive disorder

  2022cites this paper
• Non-sedative cortical EEG signatures of allopregnanolone and functional comparators

  2022cites this paper
• Analyzing the mechanisms that facilitate the subtype-specific assembly of γ-aminobutyric acid type A receptors

  2022cites this paper
• Cys-loop receptors on cannabinoids: All high?

  2022cites this paper
• Relating neurosteroid modulation of inhibitory neurotransmission to behaviour

  2021cites this paper
• Comment on "Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids".

  2021cites this paper
• Physiological role for GABAA receptor desensitization in the induction of long-term potentiation at inhibitory synapses

  2021cites this paper
• Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women

  2021cites this paper
• Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder.

  2021cites this paper
• Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition.

  2020cites this paper
• [Ketamine, psilocybine, and rapid acting antidepressant: new promise for psychiatry?]

  2020cites this paper
• Modern approaches to the pharmacotherapy of postpartum depression

  2020cites this paper
• Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator

  2020influential citation
• Neuroactive Steroids in Hypoxic–Ischemic Brain Injury: Overview and Future Directions

  2020cites this paper
• Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond

  2019cites this paper
• Metabotropic, but not allosteric, effects of neurosteroids on GABAergic inhibition depend on the phosphorylation of GABAA receptors

  2019cites this paper
• SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies

  2019cites this paper
• Brexanolone, a neurosteroid antidepressant, vindicates the GABAergic deficit hypothesis of depression and may foster resilience

  2019cites this paper
• The Functional Role of Spontaneously Opening GABAA Receptors in Neural Transmission

  2019cites this paper
• Neuroactive Steroids and GABAergic Involvement in the Neuroendocrine Dysfunction Associated With Major Depressive Disorder and Postpartum Depression

  2019cites this paper
• Neuroactive Steroids Reverse Tonic Inhibitory Deficits in Fragile X Syndrome Mouse Model

  2019influential citation
• Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor

  2019cites this paper
• A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

  2019cites this paper
• Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease

  2019cites this paper
• The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats

  2019cites this paper
• Allopregnanolone-based treatments for postpartum depression: Why/how do they work?

  2019cites this paper
• Breakthroughs in neuroactive steroid drug discovery.

  2018cites this paper
• 3β-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic δ-Subunit γ-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield

  2018cites this paper
• Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder

  2018cites this paper
• The relationship between GABA and stress: ‘it's complicated’

  2018cites this paper
• GABA type a receptor trafficking and the architecture of synaptic inhibition

  2018cites this paper
• A Novel, Synthetic, Neuroactive Steroid Is Effective at Decreasing Depression-Like Behaviors and Improving Maternal Care in Preclinical Models of Postpartum Depression

  2018influential citation
• Developmental seizures and mortality result from reducing GABAA receptor α2-subunit interaction with collybistin

  2018cites this paper
• Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy

  2018cites this paper
• Stress and Seizures: Space, Time and Hippocampal Circuits.

  2017cites this paper
• Mild cognitive impairment due to Alzheimer disease: Contemporary approaches to diagnostics and pharmacological intervention

  2017cites this paper
• Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models.

  2017cites this paper
• Decreased surface expression of the δ subunit of the GABAA receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome.

  2017influential citation
• Title Page Title : GABA type A receptor trafficking and the architecture of synaptic inhibition Running title : GABA A R trafficking and synapses

  2017cites this paper